Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
Molecular Cancer Therapeutics
|
October 15, 2008
Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines
Philip L Lorenzi, Jenny Llamas, Michele Gunsior, et al.
BMC Psychiatry
|
June 28, 2017
Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)
L Marwood, R Taylor, K Goldsmith, et al.
Biochemical Pharmacology
|
April 5, 2011
The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line
Noemi Kedei, Andrea Telek, Alexandra Czap, et al.
Pilot and Feasibility Studies
|
January 7, 2021
Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES)
N Metrebian, E Carr, K Goldsmith, et al.
Investigative Ophthalmology & Visual Science
|
September 8, 2018
Targeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma Seeds
Zachary K Goldsmith, William Coppess, Andrew S Irvine, et al.
Molecular Biology of the Cell
|
May 3, 2013
Phosphorylation of centromeric histone H3 variant regulates chromosome segregation in Saccharomyces cerevisiae
Lars Boeckmann, Yoshimitsu Takahashi, Wei-Chun Au, et al.
BMC Cancer
|
June 22, 2017
Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma
Anderson H Webb, Bradley T Gao, Zachary K Goldsmith, et al.
Journal of Cancer
|
June 22, 2016
Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin
Hong-Wu Xin, Chenwi M Ambe, Tyler C Miller, et al.
Molecular Cancer Therapeutics
|
November 8, 2006
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells
Philip L Lorenzi, William C Reinhold, Martina Rudelius, et al.
Gut
|
February 16, 2013
Label-retaining liver cancer cells are relatively resistant to sorafenib
Hong-Wu Xin, Chenwi M Ambe, Danielle M Hari, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
Molecular Cancer Therapeutics
|
October 15, 2008
Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines
Philip L Lorenzi, Jenny Llamas, Michele Gunsior, et al.
BMC Psychiatry
|
June 28, 2017
Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)
L Marwood, R Taylor, K Goldsmith, et al.
Biochemical Pharmacology
|
April 5, 2011
The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line
Noemi Kedei, Andrea Telek, Alexandra Czap, et al.
Pilot and Feasibility Studies
|
January 7, 2021
Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES)
N Metrebian, E Carr, K Goldsmith, et al.
Investigative Ophthalmology & Visual Science
|
September 8, 2018
Targeting the Platelet-Derived Growth Factor-beta Stimulatory Circuitry to Control Retinoblastoma Seeds
Zachary K Goldsmith, William Coppess, Andrew S Irvine, et al.
Molecular Biology of the Cell
|
May 3, 2013
Phosphorylation of centromeric histone H3 variant regulates chromosome segregation in Saccharomyces cerevisiae
Lars Boeckmann, Yoshimitsu Takahashi, Wei-Chun Au, et al.
BMC Cancer
|
June 22, 2017
Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma
Anderson H Webb, Bradley T Gao, Zachary K Goldsmith, et al.
Journal of Cancer
|
June 22, 2016
Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin
Hong-Wu Xin, Chenwi M Ambe, Tyler C Miller, et al.
Molecular Cancer Therapeutics
|
November 8, 2006
Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells
Philip L Lorenzi, William C Reinhold, Martina Rudelius, et al.
Gut
|
February 16, 2013
Label-retaining liver cancer cells are relatively resistant to sorafenib
Hong-Wu Xin, Chenwi M Ambe, Danielle M Hari, et al.
Page
of 14